thorium Th 227 anetumab corixetan
A radioimmunoconjugate consisting of anetumab, a human immunoglobulin G1 (IgG1) monoclonal antibody directed against the cell surface glycoprotein mesothelin, conjugated to the chelating agent corixetan, and labeled with the alpha-emitting radioisotope thorium Th 227, with potential antineoplastic activity. Upon administration of thorium Th 227 anetumab corixetan, the anetumab moiety binds to the tumor-associated antigen (TAA) mesothelin, delivering a cytotoxic dose of alpha radiation to cells expressing mesothelin.
| Synonym: | 227Th anetumab corixetan thorium Th 227 monoclonal antibody BAY2287411 thorium-227-labeled anetumab thorium-227-labeled antibody-chelator conjugate BAY2287411 |
|---|---|
| Code name: | BAY 2287411 BAY2287411 |